T. Millar

First name
T.
Last name
Millar
Domzaridou, E., Carr, M. J., Millar, T., Webb, R. T., & Ashcroft, D. M. (2023). Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records. Addiction. http://doi.org/10.1111/add.16306
Domzaridou, E., Carr, M. J., Webb, R. T., Millar, T., & Ashcroft, D. M. (2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. Lancet Reg Health Eur, 22, 100489. http://doi.org/10.1016/j.lanepe.2022.100489
Hickman, M., Steer, C., Tilling, K., Lim, A. G., Marsden, J., Millar, T., et al. (2018). The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction. http://doi.org/10.1111/add.14188
Macleod, J., Steer, C., Tilling, K., Cornish, R., Marsden, J., Millar, T., et al. (2019). Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med. http://doi.org/10.1371/journal.pmed.1002965